Dr. Crawford on Ongoing Trials of Genetic Testing for Prostate Cancer

E. David Crawford, MD
Published Online: Wednesday, Apr 19, 2017



E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses ongoing trials regarding genetic testing for patients with prostate cancer.

There are trials that are beginning predicated on advanced disease but overall there is not much data available in this space, explains Crawford.

Developing more data and determining the impact that genetic testing can have on patients with prostate cancer is an exciting time for the field, states Crawford.
 


E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses ongoing trials regarding genetic testing for patients with prostate cancer.

There are trials that are beginning predicated on advanced disease but overall there is not much data available in this space, explains Crawford.

Developing more data and determining the impact that genetic testing can have on patients with prostate cancer is an exciting time for the field, states Crawford.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication